To evaluate whether HSA–CDDP can be taken up by glioblastoma cells in a SPARC-mediated HSA-dependent manner, we performed cellular uptake imaging using confocal microscopy based on our previous paper [17,30]. The gene discussed is ALB; the disease is glioblastoma.